HOME >> BIOLOGY >> NEWS
LabNotes -- Research highlights from Pacific Northwest National Laboratory

System helps prevent power grid failures - In the age of electricity deregulation, information has become equivalent to power. Providers who know of potential outage conditions often can take action to ensure "the lights stay on" if they have the right information. A system developed using technology from the Department of Energy's Pacific Northwest National Laboratory and the Bonneville Power Administration soon will provide this key information to California power providers that are challenged by increased loads and decreased supply.

The system, called WAMS for Wide Area Measurement System, continuously monitors grid performance across the Western power system. It provides operators with high- quality data and analysis tools to detect impending grid emergencies or to mitigate grid outages.

WAMS data access and toolsets are being provided to California's Independent System Operator, which manages wholesale power delivery in that state. Funding is being provided by the California Energy Commission and DOE through the Consortium for Electric Reliability Technologies. PNNL is a consortium member. WAMS' initial development was supported by DOE and the Electric Power Research Institute.

DOE named WAMS one of the top 100 innovations since that agency was created in 1977.

Biotechnology strikes out chlorinated solvents - A Pacific Northwest National Laboratory cleanup technology that's attacking chromate seeping into groundwater at the the Department of Energy's Hanford site in Washington state now stands ready to serve the military and commercial companies with another troubling environmental concern: halting the seepage of chlorinated solvents.

In-Situ Redox Manipulation, or ISRM, uses standard groundwater monitoring wells to inject chemical reagents and buffers into the subsurface, creating a barrier that organic contaminants, such as trichloroethylene, move through then are destroyed in the process. Laboratory and field tests conducted a
'"/>

Contact: Greg Koller
greg.koller@pnl.gov
509-372-4864
DOE/Pacific Northwest National Laboratory
10-Jan-2001


Page: 1 2 3

Related biology news :

1. LabNotes -- Research highlights from Pacific Northwest National Laboratory
2. LabNotes -- research highlights from Pacific Northwest National Laboratory
3. LabNotes - Spring 2001
4. LabNotes -- Research highlights from Pacific Northwest National Laboratory
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
8. Researchers identify protein promoting vascular tumor growth
9. Researchers devise potent new tools to curb ivory poaching
10. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
11. Researchers ID chlorophyll-regulating gene

Post Your Comments:
(Date:5/23/2013)... pathogens are growing increasingly resistant to the conventional antibiotics ... scientists has synthesized a potent new class of compounds ... , Writing online in the Journal of the ... of Wisconsin-Madison chemistry Professor Helen Blackwell describes agents that ... Staphylococcus aureus , a bacterium at the root of ...
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
(Date:5/22/2013)... (May 22, 2013)The omega 3 fatty acids in fish ... diseaseso much so that the American Heart Association currently ... week, particularly fatty varieties rich in omega 3s. However, ... mystery. In a new study, scientists led by Jason ... this phenomenon by providing evidence that fish oil might ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2Tests lead to doubling of fuel cell life 2Fish oil may help the heart beat mental stress 2
(Date:5/23/2013)... MENLO PARK, Calif. , May 23, 2013 /PRNewswire/ ... an oral treatment for pain has reached an important ... clinical trial of VBY-036 - a selective cathepsin S ... of VBY-036 is a double-blind, randomized, placebo-controlled study designed ... escalating doses of VBY-036 in healthy adults. ...
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
(Date:5/23/2013)... May 23, 2013 Pressure BioSciences, Inc. (OTCQB: ... Company will host a teleconference to discuss its First ... update. The teleconference information is provided below: ... Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); ... (Int,l) Passcode: VS22823 For those unable to ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
Cached News: